Board-certified ophthalmologist offering advanced diagnosis and treatment for macular degeneration, including geographic atrophy and intravitreal injections, in Roslyn Heights, Nassau County, and the North Shore of Long Island.

Macular degeneration is a chronic eye condition that affects the macula, the central portion of the retina responsible for sharp, detailed vision. This condition impairs daily activities such as reading, driving, and recognizing faces. Most commonly age-related, macular degeneration can progress gradually or, in some cases, more rapidly, leading to complications like geographic atrophy. 

At Politi Eyecare & Aesthetics, we manage macular degeneration through a comprehensive, evidence-based approach aimed at preserving vision and slowing the progression of the disease. We utilize advanced retinal imaging to accurately diagnose both dry (non-neovascular) and wet (neovascular) forms of macular degeneration, which helps guide individualized treatment planning. 

Treatment recommendations may include close monitoring, nutritional guidance, laser-based therapies, or intravitreal injections when necessary, particularly for those experiencing more severe symptoms.

Geographic atrophy (GA) is an advanced form of dry macular degeneration, marked by the progressive loss of retinal cells in the macula, which ultimately leads to permanent central vision loss over time. Unlike wet macular degeneration, GA does not involve the growth of abnormal blood vessels, but it can still have a significant impact on visual function and overall quality of life.

Recent advances in ophthalmology have introduced innovative intravitreal injections for geographic atrophy, aimed at slowing the progression of retinal damage in specific patients. While these treatments do not restore lost vision, they may help preserve remaining retinal function when administered at appropriate stages of the disease.

At Politi Eyecare & Aesthetics, patients diagnosed with geographic atrophy receive comprehensive retinal imaging and evaluation to determine if emerging treatment options, including intravitreal injections, may be suitable. Treatment decisions are tailored to each individual based on the severity of the disease, risk of progression, and overall ocular health.

Intravitreal injections are a primary treatment for wet macular degeneration, as they help reduce abnormal blood vessel growth and retinal fluid leakage. These injections are administered directly into the eye under sterile conditions and are crucial for stabilizing or improving vision in many patients with macular degeneration. For those affected by geographic atrophy, the treatment frequency is tailored based on individual disease activity and response.

In select cases, laser-based treatments may be utilized to manage certain complications related to macular degeneration, including geographic atrophy. These procedures are carefully chosen based on retinal findings, and intravitreal injections may also be considered to help preserve remaining vision and reduce disease progression.